Advertisement

Home Blood Pressure Monitoring in Children, Pregnancy, and Chronic Kidney Disease

  • Anastasios Kollias
  • Andrew Shennan
  • Rajiv Agarwal
  • Angeliki Ntineri
  • George S. StergiouEmail author
Chapter
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)

Abstract

The accurate diagnosis and management of hypertension is based on out-of-office blood pressure (BP) measurements. Home BP monitoring has several advantages over office and ambulatory BP monitoring including convenience and the ability to obtain repeated measurements in the usual environment of the individual over several days, weeks, or months. Evidence on the role of home BP monitoring in special populations including children and adolescents, pregnant women, and patients with renal disease is currently accumulating. In children, as in adults, home BP appears to be a useful alternative to ambulatory monitoring in detecting white-coat and masked hypertension and in following children treated for hypertension. In pregnancy, the potential for home BP monitoring in following women with hypertension and in the early identification of preeclampsia is fundamental. In patients with chronic kidney disease home BP has been shown to be prognostically superior to office BP in predicting end-stage renal disease. Moreover, home BP recordings are superior to peridialysis BP measurements in predicting all-cause mortality. Duplicate, morning and evening home BP measurements for 7 days (minimum of 3 days) are recommended for optimal home BP evaluation. In end-stage renal disease patients on hemodialysis, it is recommended that home BP be measured twice daily, at bedtime and on waking, after the midweek dialysis for 4 days. Automated oscillometric devices that have been successfully validated in adults may not be accurate in children, pregnant women, and in patients with nephropathy, and separate validation is required.

Keywords

Children Adolescents Pregnancy Preeclampsia Chronic kidney disease End-stage renal disease 

References

  1. 1.
    Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887–920.CrossRefGoogle Scholar
  2. 2.
    Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:pii: e20171904.CrossRefGoogle Scholar
  3. 3.
    Stergiou GS, Alamara CV, Vazeou A, Stefanidis CJ. Office and out-of-office blood pressure measurement in children and adolescents. Blood Press Monit. 2004;9:293–6.CrossRefGoogle Scholar
  4. 4.
    Stergiou GS, Ntineri A, Kollias A, Stambolliu E, Kapogiannis A, Vazeou A, et al. Home blood pressure monitoring in pediatric hypertension: the US perspective and a plan for action. Hypertens Res. 2018;41:662–8.CrossRefGoogle Scholar
  5. 5.
    Stergiou GS, Ntineri A. Methodology and applicability of home blood pressure monitoring in children and adolescents. In: Flynn J, Ingelfinger J, Redwine K, editors. Pediatric Hypertension. Cham: Springer; 2018. p. 305–21.  https://doi.org/10.1007/978-3-319-31107-4_45.CrossRefGoogle Scholar
  6. 6.
    Bald M, Hoyer PF. Measurement of blood pressure at home: survey among pediatric nephrologists. Pediatr Nephrol. 2001;16:1058–62.CrossRefGoogle Scholar
  7. 7.
    Woroniecki RP, Flynn JT. How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol. 2005;20:791–7.CrossRefGoogle Scholar
  8. 8.
    Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, Dacou-Voutetakis C, Mountokalakis TD. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit. 2005;10:143–7.CrossRefGoogle Scholar
  9. 9.
    Stergiou GS, Nasothimiou EG, Giovas PP, Rarra VC. Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study. Hypertens Res. 2009;32:311–5.CrossRefGoogle Scholar
  10. 10.
    Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008;26:1556–62.CrossRefGoogle Scholar
  11. 11.
    Stergiou GS, Giovas PP, Kollias A, Rarra VC, Papagiannis J, Georgakopoulos D, et al. Relationship of home blood pressure with target-organ damage in children and adolescents. Hypertens Res. 2011;34:640–4.CrossRefGoogle Scholar
  12. 12.
    Kollias A, Dafni M, Poulidakis E, Ntineri A, Stergiou GS. Out-of-office blood pressure and target organ damage in children and adolescents: a systematic review and meta-analysis. J Hypertens. 2014;32:2315–31.CrossRefGoogle Scholar
  13. 13.
    Stergiou GS, Boubouchairopoulou N, Kollias A. Accuracy of automated blood pressure measurement in children: evidence, issues, and perspectives. Hypertension. 2017;69:1000–6.CrossRefGoogle Scholar
  14. 14.
    Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB. Home blood pressure normalcy in children and adolescents: the Arsakeion School study. J Hypertens. 2007;25:1375–9.CrossRefGoogle Scholar
  15. 15.
    Stergiou GS, Yiannes NG, Rarra VC. Validation of the Omron 705 IT oscillometric device for home blood pressure measurement in children and adolescents: the Arsakion School study. Blood Press Monit. 2006;11:229–34.CrossRefGoogle Scholar
  16. 16.
    Stergiou GS, Karpettas N, Panagiotakos DB, Vazeou A. Comparison of office, ambulatory and home blood pressure in children and adolescents on the basis of normalcy tables. J Hum Hypertens. 2011;25:218–23.CrossRefGoogle Scholar
  17. 17.
    Stergiou GS, Christodoulakis G, Giovas P, Lourida P, Alamara C, Roussias LG. Home blood pressure monitoring in children: how many measurements are needed? Am J Hypertens. 2008;21:633–8.CrossRefGoogle Scholar
  18. 18.
    Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH. Blood pressure measurement in pregnancy. Obstet Gynaecol. 2015;17:91–8.Google Scholar
  19. 19.
    Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–7.CrossRefGoogle Scholar
  20. 20.
    Shennan AH, Green M, Chappell LC. Maternal deaths in the UK: pre-eclampsia deaths are avoidable. Lancet. 2017;389:582–4.CrossRefGoogle Scholar
  21. 21.
    Shennan A, Gupta M, Halligan A, Taylor DJ, de Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996;347:139–42.CrossRefGoogle Scholar
  22. 22.
    Nathan HL, Vousden N, Lawley E, de Greeff A, Hezelgrave NL, Sloan N, et al. Development and evaluation of a novel vital signs alert device for use in pregnancy in low-resource settings. BMJ Innov. 2018;4:192–8.CrossRefGoogle Scholar
  23. 23.
    Tucker KL, Bankhead C, Hodgkinson J, Roberts N, Stevens R, Heneghan C, et al. How do home and clinic blood pressure readings compare in pregnancy? Hypertension. 2018;72:686–94.CrossRefGoogle Scholar
  24. 24.
    von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.CrossRefGoogle Scholar
  25. 25.
    Bellamy L, Casas JP, Hingorami AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.CrossRefGoogle Scholar
  26. 26.
    Magee L, von Dadelszen P. Preeclampsia and increased cardiovascular risk. BMJ. 2007;335:945–6.CrossRefGoogle Scholar
  27. 27.
    Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22.CrossRefGoogle Scholar
  28. 28.
    Ross-McGill H, Hewison J, Hirst J, Dowswell T, Holt A, Brunskill P, et al. Antenatal home blood pressure monitoring: a pilot randomised controlled trial. BJOG. 2000;107:217–21.CrossRefGoogle Scholar
  29. 29.
    Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994–1001.CrossRefGoogle Scholar
  30. 30.
    Rave K, Bender R, Heise T, Sawicki PT. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy. J Hypertens. 1999;17:597–601.CrossRefGoogle Scholar
  31. 31.
    Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–11.CrossRefGoogle Scholar
  32. 32.
    Santos SF, Mendes RB, Santos CA, Dorigo D, Peixoto AJ. Profile of interdialytic blood pressure in hemodialysis patients. Am J Nephrol. 2003;23:96–105.CrossRefGoogle Scholar
  33. 33.
    Agarwal R, Lewis RR. Prediction of hypertension in chronic hemodialysis patients. Kidney Int. 2001;60:1982–9.CrossRefGoogle Scholar
  34. 34.
    Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre and post dialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1:389–98.CrossRefGoogle Scholar
  35. 35.
    Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol. 2007;2:1228–34.CrossRefGoogle Scholar
  36. 36.
    Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55:762–8.CrossRefGoogle Scholar
  37. 37.
    Agarwal R, Light RP. Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Am J Kidney Dis. 2009;54:693–701.CrossRefGoogle Scholar
  38. 38.
    da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D Jr. Cochrane renal group prospective trial register: CRG060800146. Home blood pressure monitoring in blood pressure control among haemodialysis patients: An open randomized clinical trial. Nephrol Dial Transplant. 2009;24:3805–11.CrossRefGoogle Scholar
  39. 39.
    Bishu K, Gricz KM, Chewaka S, Agarwal R. Appropriateness of antihypertensive drug therapy in hemodialysis patients. Clin J Am Soc Nephrol. 2006;1:820–4.CrossRefGoogle Scholar
  40. 40.
    Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant. 2014;29:672–81.CrossRefGoogle Scholar
  41. 41.
    Agarwal R, Andersen MJ, Light RP. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol. 2007;28:210–7.CrossRefGoogle Scholar

Copyright information

© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature 2020

Authors and Affiliations

  • Anastasios Kollias
    • 1
  • Andrew Shennan
    • 2
  • Rajiv Agarwal
    • 3
  • Angeliki Ntineri
    • 1
  • George S. Stergiou
    • 1
    Email author
  1. 1.Hypertension Center STRIDE-7National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria HospitalAthensGreece
  2. 2.Department of Women and Children’s Health, School of Life Course SciencesFoLSM, King’s CollegeLondonUK
  3. 3.Indiana University School of Medicine and Richard L. Roudebush VA Medical CenterIndianapolisUSA

Personalised recommendations